: 00:10:00 What percentage of a diabetic patient on GLP-1 have complete remission: 00:11:30 How long did it take to bring a drug to market from the moment you first discovered it: 00:23:30 What is the GLP-1 effect on cognition and dementia: 00:29:00 GLP-1 effect on kidney diseases: 00:32:00 GLP-1 positive effect on fertility: 00:35:00 GLP-1 positive effect on cancer: 00:37:30 Should a patient be on GLP-1 for life: 00:41:00 GLP-1 related side effects: 00:48:00 GLP-1 effect on resting heart rate: 00:52:30 GLP-1 related side effects: 00:48:00 GLP-1 from Lilly vs novo nordisk: 00:55:00 GLP-1 oral versus the injectable: 00:58:00 GLP-1 effect on lifespan: 01:00:30 GLP-1 effect on lifespan: 01:00:30 What led you to become a scientist: 01:03:00 The story of discovering the GLP-1: 01:04:30 How did you successfully extend the half-life of the GLP-1 agonist: 01:09:00 GLP-1 moving from once a day to once a week: 01:16:00 Top tip to improve healthspan: 01:18:00 GLP-1 Agonists: A Game-Changer for Diabetes and Obesity Dr
From the story: All have helped patients far beyond doctors initial expectations and continue to benefit millions of people every day. The Financial Times has even gone so far as to declare America may have arrived at Peak Obesity as demonstrated in this chart, thanks to these medications: I certainly think its plausible to say that GLP-1 drugs may, at this moment, be a more important innovation than generative AI
Semaglutide requires weekly injections and often causes gastrointestinal side effects, while AOD-9604 is generally well-tolerated with minimal digestive impact
[ 5 ] Stick with pharmacies that can confirm semaglutide base, sterility/endotoxin testing, and proper cold-chain shipping
Lee YJ, Javdan B, Cowan A, Smith K
According to the FDA s draft guidance, PDURS provides a practical pathway to add a companion software to the label to promote patient outcomes and safety
